Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, PNC Financial, EOG Resources and Archer-Daniels-Midland

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. The Zacks analyst believes that J&J has been witnessing significant generic/biosimilar headwinds in the Pharma unit in 2019. However, the unit is performing above-market levels, supported by contribution from new drugs like Tremfya and successful label expansion of cancer drugs like Imbruvica and Darzalex and immunology drug, Stelara. Shares of Eli Lilly have gained 9.6% in the past three months against the Zacks Large Cap Pharmaceuticals industry’s rise of 11.1%. Click to get this free report The PNC Financial Services Group, Inc (PNC) : Free Stock Analysis Report Eli Lilly and Company (LLY) : Free Stock Analysis Report Johnson & Johnson (JNJ) : Free Stock Analysis Report EOG Resources, Inc. (EOG) : Free Stock Analysis Report Archer Daniels Midland Company (ADM) : Free Stock Analysis Report To read this article on click here.

First found on: And then on: 1 other references